Announced Thu, 13 Aug · 15:04 IST
Q1 FY27 Unaudited Results Published in Newspapers
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹39.29
prior close
₹36.83
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.5-2.2—-3.4-4.5-3.3-3.3-3.7-3.3+0.3-5.9——
Up moveDown movePending
AI summary
Sandu Pharmaceuticals published its Q1 FY27 unaudited results (quarter ended 30 June 2026) in Navprabha and Navhind Times on 13 Aug 2026. Total income from operations was Rs 1640.62 lakhs versus Rs 1671.67 lakhs in Q1 FY26. Net profit after tax rose to Rs 22.82 lakhs (Rs 22.33 lakhs YoY). EPS stood at Rs 0.37 versus Rs 0.23 YoY. Board approved results on 11 Aug 2026.
Likely market impact
Slight YoY revenue dip but profit and EPS improved, indicating better margins; results were already filed with BSE.